Patents by Inventor Syed M. Shah

Syed M. Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Succinate Salt of O-Desmethyl-Venlafaxine
    Publication number: 20090018208
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 15, 2009
    Applicant: Wyeth
    Inventors: Anthony F. Hadfield, Syed M. Shah, Michael W. Winkley, Karen W. Sutherland, Jmaes A. Provost, Aeri Park, Rex A. Shipplett, Brenton W. Russell, Beat T. Weber
  • Treating cystic fibrosis with antibiotics via a swirler delivery
    Publication number: 20070286817
    Abstract: The present invention is directed to a method of treating respiratory disorders by delivering an aerosol composition of an antibiotic drug to the lung alveoli.
    Type: Application
    Filed: June 5, 2007
    Publication date: December 13, 2007
    Applicant: Wyeth
    Inventors: Hanumantharao Tatapudy, Syed M. Shah
  • Solid dosage formulations
    Publication number: 20070259041
    Abstract: Solid dosage formulations are provided for a compound having the formula: wherein R2 is Cl, F, Br, CH3, CF3, SCH3, NHCH3, NO2, CN, OH, OC1—C6 alkyl, or substituted OC1—C6 alkyl, or a prodrug or a pharmaceutically acceptable salt thereof. Formulations for tablets and multiparticulates containing a compound according to the above formula, a rate controlling component, and a binder are described, including formulations containing a seal coating, release rate controlling coating, and/or enteric coating. Pharmaceutical uses and kits thereof are also described.
    Type: Application
    Filed: May 3, 2007
    Publication date: November 8, 2007
    Applicant: Wyeth
    Inventors: Christopher Richard Diorio, Eric Ehrnsperger, Syed M. Shah
  • Compositions containing pipercillin and tazobactam useful for injection
    Patent number: 6900184
    Abstract: The invention pertains to pharmaceutical compositions of Zosyn® piperacillin with tazobactam in the presence of a buffer, preferably citrate, a particulate formation inhibitor, preferably EDTA optionally an aminoglycoside which when frozen and thawed or lyophilized and reconstituted reform a solution which has decreased particulate formation.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: May 31, 2005
    Assignee: Wyeth Holdings Corporation
    Inventors: Jonathan Marc Cohen, Syed M. Shah, Christian Luther Ofslager, Mahdi Fawzi
  • B-ring estratrienes
    Patent number: 6818636
    Abstract: This invention provides 3&bgr;-hydroxy-5,7,9-estratriene-17-one and a pharmaceutically acceptable salt of its 3-sulfate ester, which is useful as an estrogen.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: November 16, 2004
    Assignee: Wyeth
    Inventors: Syed M. Shah, Panolil Raveendranath, Michael Z. Kagan
  • Compositions containing pipercillin and tazobactam sodium useful for injection
    Publication number: 20040204372
    Abstract: The invention pertains to pharmaceutical compositions of Zosyn® in the presence of a buffer, preferably citrate, a particulate formation inhibitor, preferably EDTA optionally an aminoglycoside which when frozen and thawed or lyophilized and reconstituted reform a solution which has decreased particulate formation.
    Type: Application
    Filed: April 14, 2003
    Publication date: October 14, 2004
    Applicant: Wyeth Holdings Corporation
    Inventors: Jonathan Marc Cohen, Syed M. Shah, Christian Luther Ofslager, Mahdi Fawzi
  • Pregnanes
    Patent number: 6713465
    Abstract: This invention provides a pharmaceutically acceptable salt of 5&agr;-pregn-16-en-3&bgr;-ol-20-one 3-sulfate ester, which is useful as a progestational agent.
    Type: Grant
    Filed: November 1, 1999
    Date of Patent: March 30, 2004
    Assignee: Wyeth
    Inventors: Reinhold H. W. Bender, Mahdi B. Fawzi, Horace Fletcher, III, George O. Morton, Syed M. Shah, Xuejun Tang
  • Novel succinate salt of O-desmethyl-venlafaxine
    Publication number: 20040044241
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: September 4, 2003
    Publication date: March 4, 2004
    Applicant: Wyeth
    Inventors: Anthony F. Hadfield, Syed M. Shah, Michael W. Winkley, Karen W. Sutherland, James A. Provost, Aeri Park, Rex A. Shipplett, Brenton W. Russell, Beat T. Weber
  • B-ring estratriene diols
    Patent number: 6693207
    Abstract: This invention provides estrogenic agents having the formula wherein A and B are each, independently, R is SO3−X+; X+ is alkali metal, alkaline earth metal, ammonium, alkylammonium containing 1-6 carbon atoms, or dialkylammonium containing 1-6 carbon atoms in each alkyl group, or trialkylammonium containing 1-6 carbon atoms in each alkyl group; with the proviso that at least one of A or B is
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: February 17, 2004
    Assignee: Wyeth
    Inventors: Michael Z. Kagan, Panolil Raveendranath, Syed M. Shah, Michael W. Winkley
  • Succinate salt of O-desmethyl-venlafaxine
    Patent number: 6673838
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: January 6, 2004
    Assignee: Wyeth
    Inventors: Anthony F. Hadfield, Syed M. Shah, Michael W. Winkley, Karen W. Sutherland, James A. Provost, Aeri Park, Rex A. Shipplett, Brenton W. Russell, Beat T. Weber
  • Estrenes
    Patent number: 6649779
    Abstract: This invention provides a pharmaceutically acceptable salt of 3&bgr;-hydroxy-5(10)-estrene-17-one 3-sulfate ester and a pharmaceutically acceptable salt of 3&agr;-hydroxy-5(10)-estrene-17-one 3-sulfate ester, which are useful as an estrogens.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: November 18, 2003
    Assignee: Wyeth
    Inventors: Michael Z. Kagan, Fangming Kong, Leonard A. McDonald, Panolil Raveendranath, Syed M. Shah, Joseph Zeldis
  • Amiodarone solutions suitable for intravenous administration
    Publication number: 20030139468
    Abstract: Parenteral solutions suitable for intravenous injection are provided comprising amiodarone in an amount of from 0.9 mg/ml to 30 mg/ml, a lactic acid buffer and water, the solution having a pH of 2.5 to 4.5.
    Type: Application
    Filed: January 22, 2002
    Publication date: July 24, 2003
    Applicant: American Home Products Corporation
    Inventors: Mahdi B. Fawzi, Christian L. Ofslager, Yong J. Lee, Syed M. Shah
  • B-ring estratrienes
    Publication number: 20030109513
    Abstract: This invention provides 3&bgr;-hydroxy-5,7,9-estratriene-17-one and a pharmaceutically acceptable salt of its 3-sulfate ester, which is useful as an estrogen.
    Type: Application
    Filed: January 21, 2003
    Publication date: June 12, 2003
    Applicant: Wyeth
    Inventors: Syed M. Shah, Panolil Raveendranath, Michael Z. Kagan
  • Novel succinate salt of O-desmethyl-venlafaxine
    Publication number: 20030045583
    Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.
    Type: Application
    Filed: February 11, 2002
    Publication date: March 6, 2003
    Applicant: American Home Products Corporation
    Inventors: Anthony F. Hadfield, Syed M. Shah, Michael W. Winkley, Karen W. Sutherland, James A. Provost, Aeri Park, Rex A. Shipplett, Brenton W. Russell, Beat T. Weber
  • B-ring estratrienes
    Patent number: 6525039
    Abstract: This invention provides 3&bgr;-hydroxy-5,7,9-estratriene-17-one and a pharmaceutically acceptable salt of its 3-sulfate ester, which is useful as an estrogen.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: February 25, 2003
    Assignee: Wyeth
    Inventors: Syed M. Shah, Panolil Raveendranath, Michael Z. Kagan
  • B-ring estratriene diols
    Publication number: 20020156060
    Abstract: This invention provides estrogenic agents having the formula 1
    Type: Application
    Filed: June 5, 2002
    Publication date: October 24, 2002
    Applicant: Wyeth
    Inventors: Michael Z. Kagan, Panolil Raveendranath, Syed M. Shah, Michael W. Winkley
  • Estrenes
    Publication number: 20020151532
    Abstract: This invention provides a pharmaceutically acceptable salt of 3&bgr;-hydroxy-5(10)-estrene-17-one 3-sulfate ester and a pharmaceutically acceptable salt of 3&agr;-hydroxy-5(10)-estrene-17-one 3-sulfate ester, which are useful as an estrogens.
    Type: Application
    Filed: June 5, 2002
    Publication date: October 17, 2002
    Applicant: Wyeth
    Inventors: Michael Z. Kagan, Fangming Kong, Leonard A. McDonald, Panolil Raveendranath, Syed M. Shah, Joseph Zeldis
  • Estradienes
    Patent number: 6458778
    Abstract: This invention provides estra-5(10),7-dien-3&bgr;-ol-17-one or a pharmaceutically acceptable salt of its 3-sulfate ester, estra-5(10),7-dien-3&bgr;-ol-17-one 3-glucuronide or a pharmaceutically acceptable salt thereof, estra-5(10),7-dien-3&agr;-ol-17-one or a pharmaceutically acceptable salt of its 3-sulfate ester, estra-5(10),7-dien-3&bgr;-ol-17-one 3-glucuronide or a pharmaceutically acceptable salt thereof, estra-5(10),7-dien-3&bgr;-ol-17-one 3-alkali metal salt, and estra-5(10),7-dien-3&agr;-ol-17-one 3-alkali metal salt which are useful as estrogenic agents.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: October 1, 2002
    Assignee: Wyeth
    Inventors: Fangming Kong, Leonard A. McDonald, Michael Z. Kagan, Syed M. Shah, Panolil Raveendranath, Mark A. Collins
  • Method of providing coginition enhancement with 5&agr;-pregnan-3&bgr;-ol-20-one sulfate
    Patent number: 6395723
    Abstract: This invention provides a method of providing progestational therapy to a mammal in need thereof which comprises administering a progestationally effective amount of a pharmaceutically acceptable salt of 5&agr;-pregnan-3&bgr;-ol-20-one 3-sulfate ester to said mammal.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: May 28, 2002
    Assignee: Wyeth
    Inventors: Michael Z. Kagan, Syed M. Shah
  • Pregnan-3-ol-20-ones
    Publication number: 20020019379
    Abstract: This invention provides a method of providing progestational therapy to a mammal in need thereof which comprises administering a progestationally effective amount of a pharmaceutically acceptable salt of 5&agr;-pregnan-3&bgr;-ol-20-one 3-sulfate ester to said mammal.
    Type: Application
    Filed: October 4, 2001
    Publication date: February 14, 2002
    Applicant: American Home Products Corporation
    Inventors: Michael Z. Kagan, Syed M. Shah